GEM 21A

Welcome to the Brand page for “GEM 21A”, which is offered here for Growth factor enhanced pharmaceutical preparations which include bone allograft material for the treatment of 1) bone and soft tissue defects in a wide range of indications such as periodontal, cranio-maxillofacial (head, jaw, and face), osteoporotic, sports medicine, other orthopedic applications, and 2) related wound healing and tissue repair;.

Its status is currently believed to be active. Its class is unavailable. “GEM 21A” is believed to be currently owned by “BIOMIMETIC THERAPEUTICS, INC.”


Owner:
BIOMIMETIC THERAPEUTICS, INC.
Owner Details
Description:
Growth factor enhanced pharmaceutical preparations which include bone allograft material for the treatment of 1) bone and soft tissue defects in a wide range of indications such as periodontal, cranio-maxillofacial (head, jaw, and face), osteoporotic, sports medicine, other orthopedic applications, and 2) related wound healing and tissue repair;
Categories: GROWTH FACTOR ENHANCED PHARMACEUTICAL PREPARATIONS